Strong interaction between T allele of endothelial nitric oxide synthase with B1 allele of cholesteryl ester transfer protein TaqIB highly elevates the risk of coronary artery disease and type 2 diabetes mellitus

Human Genomics

Volumn 6, Issue 1, 2012, Pages

  Rahimi, Zohreh ^a,b   Nourozi Rad, Reza ^c   Rahimi, Ziba ^a   Parsian, Abbas ^d  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c DEZFUL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

CAD; CETP TaqIB; NOS3 G894T; T2DM; Western Iran

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CETP PROTEIN, HUMAN; CHOLESTEROL ESTER TRANSFER PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CETP TAQIB GENE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOS3 GENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; AGED; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; RISK; RISK FACTOR;

AGED; ALLELES; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS;

EID: 84876543508     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-6-20     Document Type: Article

References (30)

1. Boekholdt SM, Sacks FM, Jukema JW, Shepherd J, Freeman DJ, McMahon AD, Cambien F, Nicaud V, de Grooth GJ, Talmud PJ, Humphries SE, Miller GJ, Eiriksdottir G, Gudnason V, Kauma H, Kakko S, Savolainen MJ, Arca M, Montali A, Liu S, Lanz HJ, Zwinderman AH, Kuivenhoven JA, Kastelein JJ: Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment individual patient meta-analysis of 13677 subjects. Circulation 2005, 111:278-287.
2. de Grooth GJ, Klerkx AHEM, Stroes ESG, Stalenhoef AF, Kastelein JJ, Kuivenhoven JA: A review of CETP and its relation to atherosclerosis. J lipid Res 2004, 45:1967-1974.
3. Padmaja N, Kumar RM, Balachander J, Adithan C: Cholesteryl ester transfer protein TaqIB, -629C!A and I405V polymorphisms and risk of coronary heart disease in an Indian population. Clin Chim Acta 2009, 402:139-145.
4. Kashani Farid MA, Azizi F, Hedayati M, Daneshpour MS, Shamshiri AR, Siassi F: Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study. Lipids in Health and Disease 2010, 9:96.
5. Dixit M, Bhattacharya S, Mittal B: Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study. BMC Endocrine Disorders 2005, 5:7.
6. Chaaba R, Hammami S, Attia N, Smaoui M, Masmoudi AS, Mahjoub S, Ben Hamda K, Hammami M: Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients. Clin Biochem 2005, 38:373-378.
7. Hsieh MC, Tien KJ, Chang SJ, Lo CS, Hsin SC, Hsiao JY, Hsu SC, Liang HT, Chen HC, Shin SJ, Lin SR: Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus. Metabolism 2007, 56:745-750.
8. Relvas WG, Izar MC, Helfenstein T, Fonseca MI, Colovati M, Oliveira A, Ihara SS, Han SW, Jr Las Casas AA, Fonseca FA: Relationship between gene polymorphisms and prevalence of myocardial infarction among diabetic and non-diabetic subjects. Atherosclerosis 2005, 178:101-105.
9. Kawasaki I, Tahara H, Emoto M, Shoji T, Nishizawa Y: Relationship between TaqIB cholesteryl ester transfer protein gene polymorphism and macrovascular complications in Japanese patients with type 2 diabetes. Diabetes 2002, 51:871-874.
10. Zintzaras E, Papathanasiou AA, Stefanidis I: Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: A HuGE review and meta-analysis. Genet Med 2009, 11:695-706.
11. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka I, Takahashi N, Kaneshige T, Teraoka H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998, 32:3-8.
12. Tamemoto H, Ishikawa S, Kawakami M: Association of the Glu298Asp polymorphism of the eNOS gene with ischemic heart disease in Japanese diabetic subjects. Diabetes Res Clin Pract 2008, 80:275-279.
13. Kerkeni M, Addad F, Chauffert M, Myara A, Ben Farhat M, Miled A, Maaroufi K, Trivin F: Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clin Chem 2006, 52:53-58.
14. Motawi T, Shaker O, Taha M, Sedrak H, Nabil M: Endothelial nitric oxide synthase and angiotensinogen gene polymorphism in coronary artery diseases in Egypt. Angiology 2011, 62:191-197.
15. Liyou N, Simons L, Friedlander Y, Simons J, McCallum J, O'Shaughnessy K, Davis D, Johnson A: Coronary artery disease is not associated with the E298D variant of the constitutive, endothelial nitric oxide synthase gene. Clin Genet 1998, 54:528-529.
16. Jaramillo PC, Lanas C, Lanas F, Salazar LA: Polymorphisms of the NOS3 gene in Southern Chilean subjects with coronary artery disease and controls. Clin Chim Acta 2010, 411:258-262.
17. Andrikopoulos GK, Grammatopoulos DK, Tzeis SE, Zervou SI, Richter DJ, Zairis MN, Gialafos EJ, Sakellariou DC, Foussas SG, Manolis AS, Stefanadis CI, Toutouzas PK, Hillhouse EW, GEMIG study investigators: Association of the 894 G!T polymorphism in the endothelial nitric oxide synthase gene with risk of acute myocardial infarction. BMC Med Genet 2008, 9:43.
18. Rahimi Z, Nourozi-Rad R, Vaisi-Raygani A, Saidi MR, Rahimi Z, Ahmadi R, Yarani R, Hamzehee K, Parsian A: Association between cholesteryl ester transfer protein TaqIB variants and risk of coronary artery disease and diabetes mellitus in the population of Western Iran. Genet Test Mol Biomarkers 2012, 15:813-819.
19. Rahimi Z, Nourozi-Rad A: Association of endothelial nitric oxide synthase gene variant (G894T) with coronary artery disease in Western Iran. Angiology 2012, 63:131-137.
20. World Health Organization: Part 1. Diagnosis and classification of diabetes mellitus. In Definition, Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO; 1999:1-59.
21. Rahimi Z, Ghaderi M, Nagel RL, Muniz A: Prevalence of thrombotic risk factors among β-thalassemia patients from Western Iran. J Thromb Thrombolysis 2008, 26:229-233.
22. Jafari Y, Rahimi Z, Vaisi-Raygani A, Rezaei M: Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients. Mol Cell Biochem 2011, 353:23-34.
23. Meguro S, Takei I, Murata M, Hirose H, Takei N, Mitsuyoshi Y, Ishii K, Oguchi S, Shinohara J, Takeshita E, Watanabe K, Saruta T: Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. Atherosclerosis 2001, 156:151-156.
24. Felehgari V, Rahimi Z, Mozafari H, Vaisi-Raygani A: ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria. Mol Cell Biochem 2011, 346:23-30.
25. Liu SM, Zhou X, Zheng F, Li X, Liu F, Zhang HM, Xie Y: Novel mutations found in mitochondrial diabetes in Chinese Han population. Diabetes Res & Clin Practice 2007, 76:425-435.
26. Heilbronn LK, Noakes M, Clifton PM: Association between HDL-cholesterol and the Taq1B polymorphism in the cholesterol ester transfer protein gene in obese women. Atherosclerosis 2002, 162:419-424.
27. Bellini MH, Figueira MN, Piccoli MF, Marumo JT, Cendoroglo MS, Neto MC, Dalboni MA, Batista MC, Goes MA, Schor N: Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Nephrology 2007, 12:289-293.
28. Möllsten A, Lajer M, Jorsal A, Tarnow L: The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes. Molecular Genetics and Metabolism 2009, 97:80-84.
29. Ragia G, Nikkolaidis E, Tavridou A, Arvanitidis KI, Kanoni S, Dedoussis GV, Bougioukas G, Manolopoulos VG: Endothelial nitric oxide synthase gene polymorphisms -786 T!C and 894 G!T in coronary artery bypass graft surgery patients. Hum Genomics 2010, 4:375-383.
30. Goff WL, Guerin M, Chapman MJ: Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia. Pharmacology & Therapeutics 2004, 101:17-38.